卵巢恶性肿瘤发病率高,死亡率居女性生殖系统恶性肿瘤之首,近30年来,5年存活率一直在20～30％之间,其原因主要是因为缺乏有效的早期诊断手段。现用于临床的大多数卵巢肿瘤标志物敏感性低,特异性差,影响了在临床的广泛应用。我们联合检测血清糖类抗原 CA_(-125)、癌胚抗原(CEA)、甲胎蛋白 The incidence of ovarian cancer is high, the mortality rate ranks first in female reproductive system malignancies. In the past 30 years, the 5-year survival rate has been between 20 and 30%. The reason is mainly due to the lack of effective early diagnosis. Currently used in clinical most of the ovarian tumor markers low specificity, poor specificity, affecting the wide range of clinical applications. We jointly test serum carbohydrate antigen CA _ (- 125), carcinoembryonic antigen (CEA), alpha-fetoprotein